datetime,headline,summary,related,lang,source
2020-11-25 09:02:21-05:00,"Hemodynamic Monitoring Systems Market 2020-2028 witness robust growth factors| Edwards Lifesciences, Nihon Kohden, ICU Medical, Getinge, Draeger, Fujifilm SonoSite, Deltex Medical, Vygon, Uscom, LiDCO, Philips, CNSystems","The Global Hemodynamic Monitoring Systems Market is anticipated to reach CAGR of +7% with booming revenue of US$2.27 billion in the time frame of 2020-28. Hemodynamic monitoring systems directly measure blood pressure from inside the veins, heart and arteries. They also",EW,en,OpenPR
2020-11-18 07:29:45-05:00,"The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 17) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) ALX Oncology Holdings Inc (NASDAQ: ALXO ) (announced an oncology collaboration with Zymeworks Inc (NYSE: ZYME )) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Biodesix Inc (NASDAQ: BDSX ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN C4 Therapeutics Inc (NASDAQ: CCCC ) Champions Oncology Inc (NASDAQ: CSBR ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Edwards Lifesciences Corp (NYSE: EW ) Generation Bio Co (NASDAQ: GBIO ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Immunovant Inc (NASDAQ: IMVT ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Insmed Incorporated (NASDAQ: INSM ) Keros Therapeutics Inc (NASDAQ: KROS ) Kymera Therapeutics Inc (NASDAQ: KYMR ) LeMaitre Vascular Inc (NASDAQ: LMAT ) NeoGenomics, Inc. (NASDAQ: NEO ) Neuronetics Inc (NASDAQ: STIM ) Outset Medical Inc (NASDAQ: OM ) Prelude Therapeutics Inc (NASDAQ: PRL ) PTC Therapeutics, Inc.",EW,en,Benzinga
2020-11-17 10:40:00-05:00,"Should you invest in Edwards Lifesciences, Cisco Systems, Walmart, Coca-Cola, or Walt Disney?","NEW YORK, Nov. 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EW, CSCO, WMT, KO, and DIS. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different…",EW,en,PR Newswire
2020-11-17 07:31:00-05:00,"Global Biliary Stents Markets Report 2020 with Profiles of Abbott, Boston Scientific, Medtronic, Edward Lifesciences, CONMED and Changzhou Health Microport Medical Devices - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Global Biliary Stents Markets"" report has been added to ResearchAndMarkets.com's offering. This report covers a range of products, some of which are disease-specific and others that are more often used across all types of patients and in general for health management. The study will enable its readers to understand and gain insights into the current market, and it will also forecast the changing market scenario. The data provided can help industry players understan",EW,en,Business Wire
2020-11-06 07:17:14-05:00,"Heart Valve Market Is Thriving Worldwide |Colibri Heart Valve, Boston Scientific Corporation, Jenavalve Technology, St. Jude Medical, Cryolife, Symetis, Edwards Lifesciences, Livanova","New Study On Heart Valve Market: According to the ‘Market Growth Insight’, the Heart Valve market is anticipated to be estimated at USD XX billion along with CAGR of XX% over the forecast period 2020 - 2026. The Heart Valve study",EW,en,OpenPR
2020-10-27 19:17:56-05:00,Edwards Lifesciences Research Update: Dislocation In Valuation Remains (NYSE:EW),"Strong Q3 exit with +6.4% growth in TAVR therapy sales, in spite of pressures from COVID-19. Shareholders have enjoyed +70% gains since March, however, with high volatility to the downside, which needs to be priced into the valuation.",EW,en,Seeking Alpha
2020-10-25 00:54:45-05:00,FY2020 EPS Estimates for Edwards Lifesciences Co. Boosted by Analyst (NYSE:EW),"Edwards Lifesciences Co. (NYSE:EW) – Equities researchers at Jefferies Financial Group increased their FY2020 earnings per share estimates for shares of Edwards Lifesciences in a report released on Thursday, October 22nd. Jefferies Financial Group analyst R. Denhoy now expects that the medical research company will earn $1.91 per share for the year, up from their […]",EW,en,Zolmax News
2020-10-24 20:54:45-05:00,"Edwards Lifesciences Co. to Post FY2020 Earnings of $1.92 Per Share, SVB Leerink Forecasts (NYSE:EW)","Edwards Lifesciences Co. (NYSE:EW) – Equities research analysts at SVB Leerink upped their FY2020 earnings estimates for shares of Edwards Lifesciences in a note issued to investors on Thursday, October 22nd. SVB Leerink analyst D. Antalffy now expects that the medical research company will earn $1.92 per share for the year, up from their previous […]",EW,en,The Lincolnian
2020-10-24 08:12:41-05:00,Edwards Lifesciences (NYSE:EW) Shares Down 5.1%,"Edwards Lifesciences Co. (NYSE:EW)’s stock price was down 5.1% during mid-day trading on Thursday . The stock traded as low as $78.02 and last traded at $79.38. Approximately 6,109,832 shares traded hands during mid-day trading, an increase of 67% from the average daily volume of 3,663,267 shares. The stock had previously closed at $83.61. A […]",EW,en,The Olympia Report
2020-10-24 03:48:53-05:00,Edwards Lifesciences (NYSE:EW) Announces Quarterly Earnings Results,"Edwards Lifesciences (NYSE:EW) issued its earnings results on Wednesday. The medical research company reported $0.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.45 by $0.06, MarketWatch Earnings reports. Edwards Lifesciences had a return on equity of 29.11% and a net margin of 17.21%. Edwards Lifesciences updated its FY 2020 […]",EW,en,The Olympia Report
2020-10-24 03:16:44-05:00,Edwards Lifesciences (NYSE:EW) Updates FY 2020 After-Hours Earnings Guidance,"Edwards Lifesciences (NYSE:EW) issued an update on its FY 2020 After-Hours earnings guidance on Wednesday morning. The company provided EPS guidance of 1.85-1.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.84. Edwards Lifesciences also updated its FY20 guidance to $1.85-1.95 EPS. Shares of EW stock opened at $80.41 on Friday. […]",EW,en,Stock Observer
2020-10-23 14:48:36-05:00,"Vascular Surgery and Endovascular Procedures Market 2020 Growth Analysis: BD, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Synovis Micro Companies Alliance, Inc., pfm medical ag","Vascular Surgery and Endovascular Procedures Market By Procedure (Aneurysm Repair, Bypass Surgery-Peripheral, Carotid Angioplasty and Stenting, Carotid Endarterectomy, Dialysis Access Surgery, Endovascular Repair, Stent Graft, Thromboendarterectomy, Thrombolytic Therapy, Varicose Vein Treatment), Applications (Government Hospitals, Private Hospitals and Surgical Clinics, Academic",EW,en,OpenPR
2020-10-22 15:18:47-05:00,Edwards Lifesciences (NYSE:EW) Stock Price Down 5.1%,"Edwards Lifesciences Co. (NYSE:EW)’s share price traded down 5.1% on Thursday . The stock traded as low as $78.02 and last traded at $79.38. 6,109,832 shares changed hands during trading, an increase of 67% from the average session volume of 3,663,267 shares. The stock had previously closed at $83.61. EW has been the subject of […]",EW,en,US Banking News
2020-10-22 09:35:10-05:00,Edwards Lifesciences (NYSE:EW) Given New $90.00 Price Target at Raymond James,"Edwards Lifesciences (NYSE:EW) had its price objective raised by research analysts at Raymond James from $88.00 to $90.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the medical research company’s stock. Raymond James’ price target would suggest a potential upside of 7.64% from the stock’s current price. […]",EW,en,Transcript Daily
2020-10-22 06:25:10-05:00,Investors Buy Large Volume of Put Options on Edwards Lifesciences (NYSE:EW),"Edwards Lifesciences Co. (NYSE:EW) saw some unusual options trading activity on Tuesday. Investors purchased 3,690 put options on the stock. This is an increase of 1,022% compared to the typical volume of 329 put options. Shares of Edwards Lifesciences stock opened at $83.61 on Thursday. The firm has a market cap of $51.98 billion, a […]",EW,en,Zolmax News
2020-10-21 23:42:58-05:00,Cowen Raises Edwards Lifesciences (NYSE:EW) Price Target to $100.00,"Edwards Lifesciences (NYSE:EW) had its price target increased by Cowen from $85.00 to $100.00 in a report published on Monday morning, The Fly reports. The brokerage currently has an outperform rating on the medical research company’s stock. Several other brokerages have also weighed in on EW. SVB Leerink increased their target price on Edwards Lifesciences […]",EW,en,Stock Observer
2020-10-21 23:30:50-05:00,Edwards Lifesciences Corp (EW) Q3 2020 Earnings Call Transcript | The Motley Fool,"EW earnings call for the period ending September 30, 2020.",EW,en,The Motley Fool
2020-10-21 23:23:25-05:00,Edwards Lifesciences Corp (EW) Q3 2020 Earnings Call Transcript | AlphaStreet,"Edwards Lifesciences Corp (NYSE: EW) Q3 2020 earnings call dated Oct. 21, 2020",EW,en,AlphaStreet
2020-10-21 15:15:00-05:00,Edwards Lifesciences Reports Third Quarter Results,"IRVINE, Calif., Oct. 21, 2020 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2020. Third Quarter Highlights and Outlook Sales of $1.1 billion grew 4%; similar underlying1 growth expected in the fourth quarter TAVR…",EW,en,PR Newswire
2020-10-19 20:40:47-05:00,Edwards Lifesciences (NYSE:EW) Price Target Increased to $100.00 by Analysts at Cowen,"Edwards Lifesciences (NYSE:EW) had its price objective upped by Cowen from $85.00 to $100.00 in a report published on Monday morning, The Fly reports. They currently have an outperform rating on the medical research company’s stock. Several other equities research analysts also recently weighed in on EW. Wolfe Research started coverage on shares of Edwards […]",EW,en,Daily Political
2020-10-19 08:52:06-05:00,"Artificial Heart-Lung Machine Market with Pandemic Analysis, Growth Rate, New Trend Analysis Forecast To 2027| Medtronic, C. R. Bard Inc., Edwards Lifesciences, Tianjin Medical, Jarvik Heart","Rise in the prevalence of heart diseases, awareness about cardiovascular devices, and growth in geriatric population are expected to drive the market growth. In addition, technological advancements and improvement in healthcare facilities will fuel the market growth. However, factors such",EW,en,OpenPR
2020-10-16 05:23:25-05:00,"Clot Management Devices Market to Witness Huge Growth By 2027| AngioDynamics Inc., Argon Medical Devices Inc., Boston Scientific Corporation, DePuy Synthes Inc., Edwards Lifesciences Corporation","Clot Management Devices Market analysis report is an indispensable model to have increments in business activities, qualitative work done and enhanced profits. With the utilization of well established tools and techniques in this Clot Management Devices Market business document, complex",EW,en,OpenPR
2020-10-13 09:27:18-05:00,"Global Transcatheter Embolization and Occlusion Market Trends, Outlook, Analysis and Forecast to 2026||Boston Scientific Corporation, Medtronic, Penumbra, Inc, Cook, Edwards Lifesciences Corporation",Global Transcatheter Embolization and Occlusion Market Research Report has been analyzed in detail to help clients with all the vital data to frame tactical business judgments and propose strategic growth plans. The Global Transcatheter Embolization and Occlusion Market report offers,EW,en,OpenPR
2020-10-07 09:05:00-05:00,"Edwards Lifesciences To Host Earnings Conference Call On October 21, 2020","IRVINE, Calif., Oct. 7, 2020 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW), plans to announce its operating results for the quarter ended September 30, 2020 after the market closes on Wednesday, October 21, 2020, and will host a conference call at 5:00 p.m. ET that day to discuss those…",EW,en,PR Newswire
2020-10-06 07:07:22-05:00,"Impact of Covid-19 on Hemodynamic Monitoring Devices Market 2020: Remarking Enormous Growth with Recent Trends | Edwards Lifesciences Corporation, ICU Medical, LiDCO Group, Drager Medical GmbH, etc","Industry Overview of Hemodynamic Monitoring Devices Market Report 2020 The global hemodynamic monitoring devices market was valued at USD 838.2 million in 2018 and is expected to reach USD 1.39 billion by the year 2026, at a CAGR of 6.2%. The",EW,en,OpenPR
2020-10-06 00:57:30-05:00,"Global Transcatheter Pulmonary Valve (TPV) Therapy Market Deep Study By Top Players, Segmentation & Geological Regions : 2020-2025","This report studies the Transcatheter Pulmonary Valve (TPV) Therapy Market size by top key players, regions, end industries, history data and forecast data 2020-2025. Top Key Players operating in this report are Medtronic, Edwards Lifesciences, VENUS MEDTECH. You Can Request Demo",EW,en,OpenPR
2020-09-09 09:38:00-05:00,Worldwide Tricuspid Valve Repair Devices Industry to 2024 - Players Include Abbott & Edwards Lifesciences Among Others - ResearchAndMarkets.com,"DUBLIN--(BUSINESS WIRE)--The ""Global Tricuspid Valve Repair Devices Market"" report has been added to ResearchAndMarkets.com's offering. This report was developed using extensive primary and secondary research by the publisher's analysts. Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market",EW,en,Business Wire
2020-09-04 06:00:00-05:00,"Ew, what is that? Photographer captures gross, beautiful slime moulds around Yellowknife","Slime moulds aren't well known, but they can be found everywhere, even in Antarctica. Here's a close-up look at these magical, colourful and tiny little creatures.",EW,en,CBC News
2020-09-03 06:55:02-05:00,"The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax","Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (NASDAQ: CDMO ) ( reacted to strong quarterly results) BioLife Solutions Inc (NASDAQ: BLFS ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Edwards Lifesciences Corp (NYSE: EW ) Evogene Ltd (NASDAQ: EVGN ) Fortress Biotech (NASDAQ: FBIO ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) (priced its 5.27-million-share common stock offering at $33 per share) Inspire Medical Systems Inc (NYSE: INSP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) (announced potent SARS-CoV-2 neutralizing data from COVID-19 therapeutic antibody program) West Pharmaceutical Services Inc. (NYSE: WST ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADiTx Therapeutics Inc (NASDAQ: ADTX ) (priced a $9.6-million follow-on offering) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Entera Bio Ltd (NASDAQ: ENTX ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Interpace Biosciences Inc (NASDAQ: IDXG ) Iterum Therapeutics PLC (NASDAQ: ITRM ) NanoVibronix Inc (NASDAQ: NAOV ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Nkarta Inc (NASDAQ: NKTX ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Psychemedics Corp. (NASDAQ: PMD ) Rockwell Medical Inc (NASDAQ: RMTI ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Stocks In Focus Sutro To Present Positive Phase 1 Ovarian Cancer Data In an abstract submitted to the International Gynecologic Cancer Society …","EVGN,EW",en,Benzinga
2020-09-02 11:51:00-05:00,Global Transcatheter Mitral Valve Devices Market to 2024 - Featuring Cardiac Dimensions & Edwards Lifesciences Among Others - ResearchAndMarkets.com,"DUBLIN--(BUSINESS WIRE)--The ""Global Transcatheter Mitral Valve Devices Market"" report has been added to ResearchAndMarkets.com's offering. This report was developed using extensive primary and secondary research by the publisher's analysts. Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and mar",EW,en,Business Wire
2020-08-12 03:59:00-05:00,"Global Cannula Market (2020 to 2025) - Featuring CONMED, Edwards Lifesciences & Medtronic Among Others - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Cannula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025"" report has been added to ResearchAndMarkets.com's offering. The global cannula market grew at a CAGR of around 6% during 2014-2019. A cannula is a small hollow tube with a sharp and retractable inner core that is inserted into a vein, artery or body cavity to administer medication and draw off fluids. Several types of cannula are available for performing different proce",EW,en,Business Wire
2020-08-10 03:38:07-05:00,Edwards Lifesciences : Northwestern University and Edwards Lifesciences Catastrophic Failure to Heed Minneapolis FDA Warnings in 2018 | MarketScreener,"Sheboygan, WI, In August 2020, Senior Leadership at one of Chicago's top Universities, Northwestern in Evanston and Chicago, failed to heed Federal Food and Drug Administration warnings to stop… | August 10, 2020",EW,en,MarketScreener
2020-07-24 07:15:00-05:00,Jason Tauber is crushing the market this year by finding the tech companies enabling the biggest disruptions. He told us how he's adjusting his game plan as valuations soar — and 7 of his top picks today.,"Jason Tauber manages the Disrupters portfolio for Neuberger Berman, and his strategy crushed the market and its benchmark in the first half of 2020. He told Business Insider how he invests in innovative companies. Tauber also laid out how he's adjusting his investments after many of his disrupters made tremendous gains, and what he recently added to the portfolio. Click here to sign up for our weekly newsletter Investing Insider . Visit Business Insider's homepage for more stories . Investing in potentially world-altering companies is Jason Tauber's specialty, so he's found more than one route to success. Tauber oversees the Disrupters portfolio for the investment firm Neuberger Berman , which manages $357 billion in assets. He targets companies that are on course to create a new market or remake an old one and generate big profits along the way. The strategy was created in 2015, and the firm reports that it's beaten its benchmark, the Russell 1000 Growth Index, every year since its inception, with the exception of a virtual tie in 2019.",EW,en,Business Insider
2020-07-23 15:38:59-05:00,Edwards Lifesciences Q2 earnings down 150%; EPS outlook raised (NYSE:EW),Edward Lifesciences (NYSE:EW) Q2 results: Net sales: $925.0M (-14.9%); TAVR: $594.3M (-12.3%); Surgical Structural Heart: $160.9M (-26.1%); Critical Care:,EW,en,Seeking Alpha
2020-07-23 15:15:00-05:00,Edwards Lifesciences Reports Second Quarter Results,"IRVINE, Calif., July 23, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2020. Second Quarter…",EW,en,PR Newswire
2020-07-17 17:04:21-05:00,Marvel’s first Disney+ show won’t debut in August after all,"Multiple sources confirm that Marvel's The Falcon and the Winter Soldier won't be on Disney+ in August as was originally planned due to the coronavirus pandemic. Disney shared the list of new releases for Disney+ in August, and Marvel's show wasn't on it. Marvel might announce a new premiere date soon, according to Entertainment Weekly . At the beginning of 2020, comic book fans were anticipating a huge year for the Marvel Cinematic Universe. Not only was Phase 4 of the MCU set to kick off with Black Widow in May, but over the summer, the first Marvel Studios series were going to arrive on Disney+, expanding the world of our favorite heroes even further. Sadly, a viral pandemic had other plans, and film and TV productions around the world were forced to shut down. Marvel pushed back every one of its movie releases, but we hadn't heard much of anything about the Disney+ shows. Until now. According to reports from Entertainment Weekly and our sister site TVLine , The Falcon and the Winter Soldier won't make its planned August premiere on Disney+.",EW,en,BGR
2020-07-15 09:58:10-05:00,Morgan Stanley Says Edwards Lifesciences Settlement With Abbott An 'Expensive Positive',"Edwards Lifesciences Corp (NYSE: EW ) and Abbott Laboratories (NYSE: ABT ) announced an agreement this week to settle their patent dispute. Notably, Edwards will pay Abbott $100 million in royalty expenses through 2024, according to Morgan Stanley. The Edwards Lifesciences Analyst: David Lewis reiterated an Overweight rating on Edwards Lifesciences with an $83 price target The Edwards Lifesciences Thesis: … Full story available on Benzinga.com",EW,en,Benzinga
2020-07-15 07:30:00-05:00,Paul LaViolette Appointed To Edwards Lifesciences Board Of Directors,"IRVINE, Calif., July 15, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Paul A. LaViolette has been appointed to its board of directors….",EW,en,PR Newswire
2020-07-13 15:37:20-05:00,Abbott settles heart valve patent disputes with Edwards Lifesciences (NYSE:ABT),Abbott (NYSE:ABT) announces that it has settled all outstanding patent disputes with Edwards Lifesciences (NYSE:EW) related to transcatheter mitral and tri,EW,en,Seeking Alpha
2020-07-13 15:15:00-05:00,Edwards Lifesciences Agrees To Global Transcatheter Litigation Settlement With Abbott,"IRVINE, Calif., July 13, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has reached an agreement with Abbott to settle all outstanding…",EW,en,PR Newswire
2020-07-13 15:15:00-05:00,Abbott Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences,"ABBOTT PARK, Ill., July 13, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has reached an agreement with Edwards Lifesciences Corporation to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. The…",EW,en,PR Newswire
2020-07-09 21:00:00-05:00,Trump Reaps The Whirlwind With China/Iran Mega Deal,"Trump Reaps The Whirlwind With China/Iran Mega Deal Tyler Durden Thu, 07/09/2020 - 22:00 Authored by Tom Luongo via Gold, Goats, 'n Guns blog, For more than three years I’ve tried to explain that President Trump’s foreign policy was having the exact opposite effect of its intended purpose. Trump, under the advice of people like John Bolton, Secretary of State Mike Pompeo, Israeli Prime Minister Benjamin Netanyahu and Saudi Crown Prince Mohammed bin Salman (MBS) has pursued a maximum pressure campaign against Iran in the hopes of the regime either crumbling or suing for peace. Trump was warned by both Chinese Premier Xi Jinping and Russian President Vladimir Putin that Iran would ‘rather eat dirt’ than submit to him on nuclear weapons, support for Hezbollah, Iraq and President Bashar al-Assad in Syria. In effect, Trump and Pompeo have argued for Iran to give up its sovereignty to appease the fears of Netanyahu in Israel, and they have steadfastly told Bibi and The Donald to go pound sand.",EW,en,Zero Hedge
2020-07-09 09:05:00-05:00,"Edwards Lifesciences To Host Earnings Conference Call On July 23, 2020","IRVINE, Calif., July 9, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended June 30, 2020 after the…",EW,en,PR Newswire
2020-06-09 07:57:00-05:00,Edwards Lifesciences' SAPIEN 3 THV Cleared for Use in China,Edwards Lifesciences' (EW) SAPIEN 3 THV to be used an alternative to open-heart surgery for high and extreme-risk AS patients post approval in China.,EW,en,Zacks Investment Research
2020-06-09 07:11:00-05:00,"An environmentally conscious fund manager with a 5-year winning streak against the competition lays out how she's uncovering surprising growth, and her top 3 strategies for the future","Karina Funk runs an ESG fund for Brown Advisory, and she told Business Insider how she uses environmental, social, and corporate-governance criteria to find companies that generate the biggest returns. Funk's sustainable-growth fund has beaten the typical fund in its category for five years in a row and is well on its way to a sixth. She revealed how she finds companies that generate strong returns in spite of relatively slow growth, and the most important elements of her strategy. Visit Business Insider's homepage for more stories . Karina Funk delivers a lot of surprises to her clients. For example, there's her trick of running a socially conscious ESG fund that consistently beats the rest of the market. Then there's her tactic of finding companies that don't look like strong growers on the surface but pack more punch than expected. Combined, they've helped Funk's Brown Advisory Sustainable Growth Fund generate an above-market return of more than 17% per year since its inception in June 2012.",EW,en,Business Insider
2020-06-03 12:34:55-05:00,Healthcare Stock Paints Intriguing Technical Picture,"Edwards Lifesciences is one of the best healthcare stocks to own in June, historically",EW,en,Schaeffers Investment Research
2020-06-03 01:00:00-05:00,Global Structural Heart Disease Treatment Devices Market 2020-2024 | Increasing Structural Heart Diseases to Boost Growth | Technavio,"Technavio has been monitoring the global structural heart disease treatment devices market size and it is poised to grow by USD 5.61 billion during 2020-2024, progressing at a CAGR of over 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200602005571/en/ Technavio has announced its latest market research report titled Global Structural Heart Disease Treatment Devices Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Structural Heart Disease Treatment Devices Market Download free sample report The market is fragmented, and the degree of fragmentation will accelerate during the forecast period.",EW,en,Benzinga Feeds
2020-05-26 02:39:00-05:00,Here's Why You Should Hold on to Edwards Lifesciences for Now,Investors continue to be optimistic about Edwards Lifesciences (EW) on robust demand for products and a promising surgical structural heart business.,EW,en,Zacks Investment Research
2020-05-23 10:30:42-05:00,Edwards Lifesciences (EW) Down 1% Since Last Earnings Report: Can It Rebound?,Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,EW,en,Zacks Investment Research
2020-05-14 09:00:00-05:00,"UK Catheters Market Insights 2019-2025 Featuring Profiles of Abbott Labs, BD, Boston Scientific, Edwards Lifesciences, Integra LifeSciences, J&J, and More","DUBLIN, May 14, 2020 /PRNewswire/ -- The ""UK Catheters Market 2019-2025"" report has been added to ResearchAndMarkets.com's offering. UK catheters market is expected to grow at a CAGR of around 7.2% during the forecast period. Increasing incidences of various urinary disorders such as…",EW,en,PR Newswire
2020-05-07 15:15:00-05:00,Edwards Announces Updates From Annual Meeting,"IRVINE, Calif., May 7, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced updates from its annual meeting, in which Edwards' stockholders voted with…",EW,en,PR Newswire
2020-04-30 11:01:00-05:00,"The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences","The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences",EW,en,Zacks Investment Research
2020-04-27 16:38:01-05:00,Edwards Lifesciences : ' HemoSphere Platform Gets Health Canada Indication to Treat COVID-19 Patients | MarketScreener,"By Stephen Nakrosis Edwards Lifesciences Corp. on Monday said its HemoSphere advanced monitoring platform received an indication in the treatment of Covid-19 patients from Health Canada. … | April 27, 2020",EW,en,MarketScreener
2020-04-24 15:26:32-05:00,"Hertz; J.C. Penney fall; Edwards Lifesciences, WWE rise",Stocks that moved heavily or traded substantially on Friday: Hertz; J,EW,en,ABC News
2020-04-24 10:12:00-05:00,The Zacks Analyst Blog Highlights: Intel and Edwards Lifesciences,The Zacks Analyst Blog Highlights: Intel and Edwards Lifesciences,EW,en,Zacks Investment Research
2020-04-24 09:39:00-05:00,"Edwards Lifesciences (EW) Beats on Q1 Earnings, Cuts '20 View","Amid the coronavirus impact on sales, Edwards Lifesciences (EW) witnesses growth in TAVR procedures led by strong therapy adoption across all geographies, particularly in the United States.",EW,en,Zacks Investment Research
2020-04-24 08:31:00-05:00,"Thinking about trading options or stock in Comcast, CVS Health, Danaher Corp, Edwards Lifesciences, or NVIDIA?","NEW YORK, April 24, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CMCSA, CVS, DHR, EW, and NVDA. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different…",EW,en,PR Newswire
2020-04-23 22:09:24-05:00,Edwards Lifesciences Corp (NYSE: EW) Q1 2020 Earnings Call Transcript | AlphaStreet,Final earnings conference call transcript of Edwards Lifesciences Corp - EW stock,EW,en,news.alphastreet.com
2020-04-23 17:05:00-05:00,"Intel, Edwards Lifesciences Top Q1 Earnings Estimates",The chipmaker giant and the MedTech company both outperformed expectations in their Q1 earnings reports.,EW,en,Zacks Investment Research
2020-04-23 15:37:41-05:00,"Edwards Lifesciences expects COVID-19 to subtract half a billion dollars from sales, stock gains","Edwards Lifesciences Corp. undefined announced Thursday that sales and profit for the first quarter came in higher than expectations despite COVID-19,…",EW,en,MarketWatch
2020-04-23 06:30:00-05:00,"Transcatheter Aortic Valve Replacement (TAVR) Markets, 2020-2024 | Includes Company Profiles of Edwards Lifesciences Corp, Medtronic, Boston Scientific Corp and Abbott Laboratories","DUBLIN, April 23, 2020 /PRNewswire/ -- The ""Global Transcatheter Aortic Valve Replacement (TAVR) Market: Size, Trends and Forecasts (2020-2024)"" report has been added to ResearchAndMarkets.com's offering. The global TAVR market has increased at a significant CAGR during the years…",EW,en,PR Newswire
2020-04-16 16:50:11-05:00,Edwards Lifesciences (EW) Outpaces Stock Market Gains: What You Should Know,"Edwards Lifesciences (EW) closed the most recent trading day at $217.52, moving +1.34% from the previous trading session.",EW,en,Zacks Investment Research
2020-03-06 05:50:00-05:00,Global Cerebral and Tissue Oximetry Devices Market 2020-2024 | Evolving Opportunities with Edwards Lifesciences Corp. and Hamamatsu Photonics KK | Technavio,LONDON--(BUSINESS WIRE)-- #CerebralandTissueOximetryDevicesMarket--The cerebral and tissue oximetry devices market size has the potential to grow by USD 51.31 million during 2020-2024,EW,en,Business Wire
2020-03-02 08:27:00-05:00,Here's Why You Should Buy Edwards Lifesciences Stock Now,"Investor confidence is high in Edwards Lifesciences (EW) stock, courtesy of solid prospects.",EW,en,Zacks Investment Research
2020-02-29 11:31:07-05:00,Why Is Edwards Lifesciences (EW) Down 12.5% Since Last Earnings Report?,Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,EW,en,Zacks Investment Research
2020-01-30 16:15:00-05:00,Edwards Lifesciences Reports Fourth Quarter Results,"IRVINE, Calif., Jan. 30, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended December 31, 2019. Fourth Quarter…",EW,en,PR Newswire
2020-01-23 12:42:38-05:00,Edwards Lifesciences down 5% on recent drop in heart valve replacements,"Edwards Lifesciences (EW -5.4%) slips on average volume in apparent response to a Jefferies report of a ""sharp step down"" last month in the growth of heart",EW,en,Seeking Alpha
2020-01-21 02:17:00-05:00,Here's Why You Should Retain Edwards Lifesciences Stock Now,"Investors can hold on to Edwards Lifesciences (EW) in their portfolio for now, thanks to solid prospects.",EW,en,Zacks Investment Research
2019-12-27 12:05:00-05:00,Edwards (EW) Rides on Innovation Despite Regulatory Issues,Edwards Lifesciences' (EW) HemoSphere all-in-one monitoring platform is gaining momentum on the back of a strong rollout that sees a full-market launch.,EW,en,Zacks Investment Research
2019-12-10 09:18:41-05:00,"Interoperability of India, US Naval Ships: Tactical Data inter-linking to be discussed at 2+2 Dialogue","Tactical Data Link is the means to disseminate processed information from Radars, EW, IFF, Sonars and information related to various combat function between the far-fighting Units on a battlefield.",EW,en,The Financial Express
2019-12-09 04:05:00-05:00,Edwards Lifesciences (EW) Plans Strong Long-Term TAVR Growth,"Within TAVR, Edwards (EW) expects global TAVR opportunity to exceed $7 billion by 2024.",EW,en,Zacks Investment Research
2019-12-05 07:30:00-05:00,Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference,"NEW YORK, Dec. 5, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss the company's strategy for longer-term growth, provide an update on its technology…",EW,en,PR Newswire
2019-11-22 09:31:10-05:00,Edwards Lifesciences (EW) Up 6.1% Since Last Earnings Report: Can It Continue?,Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,EW,en,Zacks Investment Research
2019-11-20 07:25:05-05:00,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 19) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Allergan plc (NYSE: AGN )(announced publication of Phase 3 study results of migraine drug candidate) Agenus Inc (NASDAQ: AGEN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares Pharma Inc (NASDAQ: ATRS )(announced a collaboration agreement with Idorsia Pharma for developing a drug-device combo for heart attack) Ardelyx Inc (NASDAQ: ARDX ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Arvinas Inc (NASDAQ: ARVN ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Cabaletta Bio Inc (NASDAQ: CABA ) CNS Pharmaceuticals Inc (NASDAQ: CNSP )(IPOed Nov. 8) Crispr Therapeutics AG (NASDAQ: CRSP )( announced positive Phase 1/2 results for gene-editing investigational therapy) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Edwards Lifesciences Corp (NYSE: EW ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Galera Therapeutics Inc (NASDAQ: GRTX )(IPOed Nov.",EW,en,Benzinga
2019-11-19 09:51:00-05:00,Edwards Lifesciences (EW) Recalls PASCAL's Guide Sheath,Edwards Lifesciences (EW) issues a product recall for its guide sheath based on report from its urgent field safety notice.,EW,en,Zacks Investment Research
2019-11-16 00:59:47-05:00,$1.15 Billion in Sales Expected for Edwards Lifesciences Corp (NYSE:EW) This Quarter,"Equities analysts forecast that Edwards Lifesciences Corp (NYSE:EW) will report $1.15 billion in sales for the current quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Edwards Lifesciences’ earnings. The highest sales estimate is $1.17 billion and the lowest is $1.14 billion. Edwards Lifesciences reported sales of $977.70 million during the same […]",EW,en,Modern Readers
2019-11-15 12:11:59-05:00,The new seal for the Navy's next aircraft carrier contains a hint about big changes coming to naval aviation,"The US Navy's latest aircraft carrier, the John F. Kennedy, will be christened in December and should be commissioned next year. The service recently published the carrier's official seal that commemorates its namesake and hints at what the future of naval aviation will look like. Visit Business Insider's homepage for more stories . This month, the US Navy unveiled the official seal for the future aircraft carrier John F. Kennedy, which was officially launched on October 29 — three months ahead of schedule. The Kennedy will be christened in Newport News, Virginia, on December 7, and even though it likely won't be commissioned into service until 2020, the carrier's seal reveals what naval aviation will look like aboard the Kennedy in the decades to come. The seal, which is meant to honor Kennedy, his Navy service, and his vision for space exploration, depicts several of the aircraft that will operate on the carrier. In front of the superstructure is what appears to be an E-2 Hawkeye early-warning aircraft, its wings folded back.",EW,en,Business Insider
2019-11-14 10:20:03-05:00,Will Edwards Lifesciences (EW) Gain on Rising Earnings Estimates?,"Edwards Lifesciences (EW) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",EW,en,Yahoo Finance
2019-11-14 08:07:04-05:00,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Nov. 13.) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bausch Health Companies Inc (NYSE: BHC ) BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) (reacted to its third-quarter results) Bristol-Myers Squibb Co (NYSE: BMY ) Celgene Corporation (NASDAQ: CELG ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Edwards Lifesciences Corp (NYSE: EW ) ESSA Pharma Inc (NASDAQ: EPIX ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) (reacted to its third-quarter results) IGM Biosciences Inc (NASDAQ: IGMS ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) ( reported an unexpected profit for its third quarter) Recro Pharma Inc (NASDAQ: REPH ) Seattle Genetics, Inc. (NASDAQ: SGEN ): filed an arbitration demand to settle dispute with DAIICHI SANKYO/S ADR (OTC: DSNKY ).",EW,en,Benzinga
2019-11-13 05:33:13-05:00,"Edwards Lifesciences Corp (NYSE:EW) CFO Scott B. Ullem Sells 7,500 Shares","Edwards Lifesciences Corp (NYSE:EW) CFO Scott B. Ullem sold 7,500 shares of the stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $234.28, for a total transaction of $1,757,100.00. Following the transaction, the chief financial officer now directly owns 17,438 shares of the company’s stock, […]",EW,en,Modern Readers
2019-11-06 01:00:00-05:00,Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe,"IRVINE, Calif. , Nov. 6, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW ), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received CE Mark to expand use of the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients diagnosed with aortic stenosis who are at low risk for open-heart surgery. The Edwards SAPIEN 3 valve is the first transcatheter aortic valve implantation (TAVI) system to have this indication in Europe . ""Now, all European patients diagnosed with aortic stenosis can be considered for TAVI with the SAPIEN 3 valve based on factors such as anatomical considerations or other individual needs rather than risk scores,"" said Prof. Helge Möllmann, Director, Clinic for Internal Medicine (Cardiology) at St. Johannes Hospital, Dortmund, Germany . ""This is particularly important for patients at low risk for surgery, whose only serious health issue may be aortic stenosis and who want to return to their lives more safely and quickly.",EW,en,Benzinga Feeds
2019-10-28 16:31:35-05:00,The CW's upcoming Arrowverse crossover will span 5 nights. Here's everything you need to know.,"The CW's upcoming Arrowverse crossover will span across five nights, beginning on Monday, December 9 and concluding on Tuesday, January 14. The event, titled ""Crisis on Infinite Earths,"" will include characters from ""Arrow,"" ""The Flash,"" ""Supergirl,"" ""Legends of Tomorrow,"" ""Batwoman,"" and ""Black Lightning."" ""Smallville"" stars Tom Welling (Clark Kent) and Erica Durance (Lois Lane) will also make appearances. Visit Insider's homepage for more stories. The Arrowverse's upcoming crossover, ""Crisis on Infinite Earths,"" is shaping up to be The CW's most ambitious one yet. The event has been teased on episodes of ""Arrow,"" ""The Flash,"" ""Supergirl,"" and ""Legends of Tomorrow."" Fans already know that ""Crisis"" will focus on the DC characters joining together to save the multiverse. There are plenty of additional details about the superhero crossover that have been revealed outside of the shows, too. As more information is revealed, here's everything we know about the upcoming crossover. 'Crisis on Infinite Earths' will span across five nights between December 2019 and January 2020 Part one will take place during ""Supergirl's"" time slot on Sunday, December 8 at 8.p.m ET.",EW,en,Business Insider
2019-10-25 07:45:07-05:00,3 Reasons Why Edwards Lifesciences (EW) Is a Great Growth Stock,Edwards Lifesciences (EW) could produce exceptional returns because of its solid growth attributes.,EW,en,Zacks Investment Research
2019-10-25 06:12:03-05:00,"The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 24) AstraZeneca plc (NYSE: AZN ) (reacted to a beat-and-raise quarter) Edwards Lifesciences Corp (NYSE: EW )( reported better-than-expected third-quarter results) Frequency Therapeutics Inc (NASDAQ: FREQ ) (IPOed Oct. 3) GlaxoSmithKline plc (NYSE: GSK )(FDA approved expanded use of Zejula) Novo Nordisk A/S (NYSE: NVO ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 24) Acorda Therapeutics Inc NASDAQ: ACOR) (announced restructuring plan, including the elimination of 25% of its workforce) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) bluebird bio Inc (NASDAQ: BLUE ) (announced resignation of chief strategy officer) Brickell Biotech Inc (NASDAQ: BBI ) CytomX Therapeutics Inc (NASDAQ: CTMX ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Gritstone Oncology Inc (NASDAQ: GRTS ) KemPharm Inc (NASDAQ: KMPH ) MacroGenics Inc (NASDAQ: MGNX ) Midatech Pharma PLC-ADR (NASDAQ: MTP ) OpGen Inc (NASDAQ: OPGN ) )(announcing pricing of previously-announced underwritten common stock offering) Opko Health Inc. (NASDAQ: OPK )(announced a follow-on offering) Orgenesis Inc (NASDAQ: ORGS ) Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN ) Titan Medical Inc. (NASDAQ: TMDI ) Stocks In Focus Melinta Gets FDA Nod For Baxdela Label Expansion; Launch to Be Delayed Due to Liquidity Concerns Melinta Therapeutics Inc (NASDAQ: MLNT ) announced FDA approval for Baxdela for the treatment of adult patients with community-acquired bacterial pneumonia, or CABP, caused by designated succeptible bacteria.",EW,en,Benzinga
2019-10-24 08:53:00-05:00,"Edwards Lifesciences (EW) Beats on Q3 Earnings, Ups EPS View",Edwards Lifesciences (EW) reports strong Q3 sales on the recent FDA indication expansion of SAPIEN 3 and SAPIEN 3 Ultra systems.,EW,en,Zacks Investment Research
2019-10-04 09:10:11-05:00,Will Edwards Lifesciences (EW) Beat Estimates Again in Its Next Earnings Report?,Edwards Lifesciences (EW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,EW,en,Zacks Investment Research
2019-09-20 08:00:06-05:00,What Makes Edwards Lifesciences (EW) a New Buy Stock,"Edwards Lifesciences (EW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",EW,en,Zacks Investment Research
2019-09-09 03:21:00-05:00,Edwards Lifesciences Hits a 52-Week High on Solid Prospects,Edwards Lifesciences (EW) gains from recent impressive developments.,EW,en,Zacks Investment Research
2019-08-23 06:17:00-05:00,Edwards Lifesciences Sapien 3 System Recall Classified Class I,Edwards Lifesciences (EW) initiated the Field Corrective Action after receiving reports of 17 injuries and a death from the use of the Sapien 3 Ultra delivery system.,EW,en,Zacks Investment Research
2019-08-22 08:30:44-05:00,Why Is Edwards Lifesciences (EW) Up 3.2% Since Last Earnings Report?,Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,EW,en,Zacks Investment Research
2019-08-19 07:18:00-05:00,Edwards Lifesciences' (EW) SAPIEN 3 TAVR Receives FDA Nod,Edwards Lifesciences (EW) plans a commercial introduction of SAPIEN 3 Ultra in Europe.,EW,en,Zacks Investment Research
2019-08-16 12:31:11-05:00,"Edwards Lifesciences, Medtronic heart valves win FDA approval for...","Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition that restricts blood flow from the heart in patients at low-risk of death linked to open-heart surgeries, the FDA said on Friday.",EW,en,Reuters UK
2019-08-13 07:45:06-05:00,Here is Why Growth Investors Should Buy Edwards Lifesciences (EW) Now,Edwards Lifesciences (EW) could produce exceptional returns because of its solid growth attributes.,EW,en,Zacks Investment Research
2019-07-26 07:58:00-05:00,"Edwards Lifesciences Corporation (EW) Shares March Higher, Can It Continue?","As of late, it has definitely been a great time to be an investor in Edwards Lifesciences Corporation (EW).",EW,en,Zacks Investment Research
2019-07-25 06:21:54-05:00,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 24) Acasti Pharma Inc (NASDAQ: ACST ) Cardiovascular Systems Inc (NASDAQ: CSII ) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Masimo Corporation (NASDAQ: MASI ) VolitionRX Ltd (NYSE: VNRX ) Edwards Lifesciences Corp (NYSE: EW )(reported a beat-and-raise second quarter) Haemonetics Corporation (NYSE: HAE ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 24) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Five Prime Therapeutics Inc (NASDAQ: FPRX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) GENFIT S A/ADR (NASDAQ: GNFT ) ContraVir Pharmaceuticals Inc (NASDAQ: HEPA) Innoviva Inc (NASDAQ: INVA ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Marinus Pharmaceuticals Inc (NASDAQ: MRNS ) Neovasc Inc (NASDAQ: NVCN ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Pluristem Therapeutics Inc. (NASDAQ: PSTI )(announced 1-for-10 reverse stock split) Regulus Therapeutics Inc (NASDAQ: RGLS )(FDA imposed partial clinical hold on its kidney disease drug) Surface Oncology Inc (NASDAQ: SURF ) Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH ) Wave Life Sciences Ltd (NASDAQ: WVE ) Stocks In Focus FDA Approves Lilly's Nasally-Administered Low Blood Sugar Drug Eli Lilly And Co (NYSE: LLY ) said the FDA has approved its Baqsimi, the first and only nasally administered glucagon to treat severe hypoglycemia in a single, fixed, 3mg dose.",EW,en,Benzinga
2019-07-24 07:49:00-05:00,"Edwards Lifesciences (EW) Beats on Q2 Earnings, Ups EPS View","Edwards Lifesciences (EW) Q2 results benefit from higher revenues, strong segmental performance and gross margin expansion.",EW,en,Zacks Investment Research
2019-07-23 16:45:06-05:00,Edwards Lifesciences (EW) Q2 Earnings and Revenues Top Estimates,"Edwards Lifesciences (EW) delivered earnings and revenue surprises of 3.76% and 4.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",EW,en,Zacks Investment Research
2019-07-18 08:49:00-05:00,What's in Store for Edwards Lifesciences' (EW) Q2 Earnings?,Edwards Lifesciences (EW) is likely to deliver a solid second quarter on robust segmental performance.,EW,en,Zacks Investment Research
2019-07-16 09:31:28-05:00,Edwards Lifesciences (EW) Reports Next Week: Wall Street Expects Earnings Growth,Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,EW,en,Zacks Investment Research
2019-05-23 08:30:47-05:00,Why Is Edwards Lifesciences (EW) Down 2.9% Since Last Earnings Report?,Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,EW,en,Zacks Investment Research
2019-04-25 03:10:00-05:00,"Edwards Lifesciences (EW) Q1 Earnings Beat, EPS View Raised",Edwards Lifesciences (EW) gains on strong segmental contributions in Q1.,EW,en,Zacks Investment Research
2019-04-24 06:22:00-05:00,Analysts Shrug Off Softness In Edwards Lifesciences' Heart Value Replacement System (NYSE:EW),Edwards Lifesciences Corp (NYSE: EW) reported Tuesday after the market close with above-consensus first-quarter results and raised its adjusted …,EW,en,Benzinga
2019-04-23 22:14:50-05:00,Edwards Lifesciences Corp (EW) Q1 2019 Earnings Call Transcript,"EW earnings call for the period ending March 31, 2019.",EW,en,The Motley Fool
2019-04-23 20:27:06-05:00,Edwards Lifesciences' (EW) CEO Mike Mussallem on Q1 2019 Results - Earnings Call Transcript,"Edwards Lifesciences Corporation (NYSE:EW) Q1 2019 Earnings Conference Call April 23, 2019, 5:00 pm ET Company Participants Mike Mussallem - Chairman & CEO",EW,en,Seeking Alpha
2019-04-23 15:18:28-05:00,"Edwards Lifesciences beats by $0.10, beats on revenue",Edwards Lifesciences (EW): Q1 Non-GAAP EPS of $1.32 beats by $0.10; GAAP EPS of $1.18. Revenue of $993M (+11.0% Y/Y) beats by $3.13M. Press Release,EW,en,Seeking Alpha
2019-04-22 16:35:59-05:00,Edwards Lifesciences Q1 2019 Earnings Preview,"Edwards Lifesciences (NYSE:EW) is scheduled to announce Q1 earnings results on Tuesday, April 23rd, after market close. The consensus EPS Estimate is $1.22",EW,en,Seeking Alpha
2019-04-22 02:28:00-05:00,Edwards Lifesciences Takes Over CAS Medical Systems for $100M,This CASMED acquisition is expected to strengthen Edwards Lifesciences' (EW) critical care portfolio and expand its footprint in the smart monitoring technology market.,EW,en,Zacks Investment Research
2019-04-18 15:33:21-05:00,Edwards completes CAS Medical buy,Edwards Lifesciences (EW) has closed its $100M acquisition of CAS Medical Systems (CASM). It announced the deal two months ago.,EW,en,Seeking Alpha
2019-04-16 09:31:22-05:00,Edwards Lifesciences (EW) Earnings Expected to Grow: Should You Buy?,Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,EW,en,Zacks Investment Research
2019-03-21 08:52:00-05:00,Edwards Lifesciences Presents Positive Partner 3 Trial Data,Edwards Lifesciences (EW) expects SAPIEN 3 to gain FDA approval for the low-risk indication in late-2019.,EW,en,Zacks Investment Research
2019-03-19 09:58:00-05:00,Edwards Lifesciences (EW) Looks Good: Stock Adds 6.2% in Session,"Edwards Lifesciences (EW) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.",EW,en,Zacks Investment Research
2019-03-19 06:40:42-05:00,"The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 18) AstraZeneca plc (NYSE: AZN )(received orphan drug status for saracatinib, its investigational therapy for idiopathic pulmonary fibrosis, a lethal lung disease) Edwards Lifesciences Corp (NYSE: EW )(released positive results for a late-stage study of its SAPIEN 3 mitral valve in patients with severe symptomatic aortic stenosis) Avedro Inc (NASDAQ: AVDR ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Dare Bioscience Inc (NASDAQ: DARE )( announced positive results for its drug for vaginal dryness drug) Ionis Pharmaceuticals Inc (NASDAQ: IONS ) Magenta Therapeutics Inc (NASDAQ: MGTA ) Orthopediatrics Corp (NASDAQ: KIDS ) PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS )(announced positive early-stage trial results for its reversal agent for the blood thinner ticagrelor) Down In The Dumps (Biotech stocks hitting 52-week lows on March 18) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) (reported that its lead candidate AKB-9778 produced negative results in a Phase 2b study evaluating it for patients with moderate-to-severe non-proliferative diabetic retinopathy) Dynavax Technologies Corporation (NASDAQ: DVAX ) Stock In Focus FDA Approves Roche's Tecentriq-chemo Combo For First-line Treatment of Small-cell Lung Cancer Roche Holdings AG Basel ADR (OTC: RHHBY ) announced FDA approval of its Tecentriq in combination with carboplatin and etoposide (chemotherapy) for the initial treatment of adults with extensive-stage small cell lung cancer .",EW,en,Benzinga
2019-03-18 09:29:29-05:00,Edwards Shares Hit Peak After Heart Device Tops Surgery in Study,Edwards Lifesciences Corp. soared by the most in two years after patients with damaged aortic valves fared better if they were treated with the company’s easier-to-implant replacement device rather than the gold-standard surgery that involves cracking open the chest.,EW,en,Bloomberg
2019-03-16 08:04:59-05:00,"Edwards, Medtronic heart valve systems prove worth in low-risk patients: studies","Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results presented on Saturday.",EW,en,Reuters
2019-03-16 08:04:59-05:00,"Edwards, Medtronic heart valve systems prove worth in low-risk...","Non-invasive heart valve replacement systems from Medtronic Plc and rival Edwards Lifesciences Corp proved as good or better than open heart surgery in younger, more active patients for whom the surgical option was deemed low risk, according to trial results presented on Saturday.",EW,en,Reuters UK
2019-03-14 06:47:56-05:00,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 13) Abbott Laboratories (NYSE: ABT ) Akari Therapeutics PLC (NASDAQ: AKTX )( reported positive pre-IND meeting with the FDA) Array Biopharma Inc (NASDAQ: ARRY ) Ascendis Pharma A/S (NASDAQ: ASND ) CareDx Inc (NASDAQ: CDNA ) Chiasma Inc (NASDAQ: CHMA ) Denali Therapeutics Inc (NASDAQ: DNLI ) Edwards Lifesciences Corp (NYSE: EW ) Eli Lilly And Co (NYSE: LLY ) Guardant Health Inc (NASDAQ: GH )(reacted to the fourth-quarter results) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Kalvista Pharmaceuticals Inc (NASDAQ: KALV ) RA Medical Systems Inc (NYSE: RMED ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Down In The Dumps (Biotech stocks hitting 52-week lows on March 13) Achaogen Inc (NASDAQ: AKAO ) Aptinyx Inc (NASDAQ: APTX ) Soleno Therapeutics Inc (NASDAQ: SLNO ) Stock In Focus Arsanis Completes X4 Merger, To Change Name To X4 Pharma X4 Pharma announced the completion of its merger with Arsanis Inc (NASDAQ: ASNS ), effective March 13.",EW,en,Benzinga
2019-03-13 19:39:50-05:00,"New Relic, Edwards Lifesciences, Aphria: 'Mad Money' Lightning Round","Jim Cramer takes a look at New Relic, Edwards Lifesciences, Aphria, NovaGold Resources, Insperity and more….APHA",EW,en,The Street
2019-03-12 11:03:15-05:00,Medical Devices Stock Price Gain Opportunity: Edwards Lifesciences,No summary available.,EW,en,Seeking Alpha
2019-03-11 08:15:16-05:00,Edwards Lifesciences invests in transcatheter device makers,No summary available.,EW,en,Seeking Alpha
2019-02-20 14:09:46-05:00,"Edwards Lifesciences: It's Expensive, But It's Recession-Proof",Edwards Lifesciences has a solid history of earnings growth with an earnings boost expected for 2019. The company is efficiently run with a proactive management,EW,en,Seeking Alpha
2019-02-19 16:41:28-05:00,Edwards' Pascal valve cleared in Europe for mitral regurgitation,No summary available.,EW,en,Seeking Alpha
2019-02-19 09:25:21-05:00,"Merger Arbitrage Mondays - February 18, 2019",No summary available.,EW,en,Seeking Alpha
2019-02-15 12:59:10-05:00,FDA issues draft guidance on non-binding feedback on inspections,No summary available.,EW,en,Seeking Alpha
2019-02-12 11:22:08-05:00,"Medical devices maintain strength, IHI up 11% ytd",No summary available.,EW,en,Seeking Alpha
2019-02-12 08:47:16-05:00,Edwards Lifesciences to acquire CAS Medical Systems for $100M,No summary available.,EW,en,Seeking Alpha
2019-01-31 22:04:06-05:00,Edwards Lifesciences Corp (EW) CEO Mike Mussallem on Q4 2018 Results - Earnings Call Transcript,No summary available.,EW,en,Seeking Alpha
2019-01-31 16:41:34-05:00,Edwards Lifesciences Q4 non-GAAP earnings up 22%,No summary available.,EW,en,Seeking Alpha
2019-01-31 16:20:22-05:00,"Edwards Lifesciences EPS in-line, beats on revenue",No summary available.,EW,en,Seeking Alpha
2019-01-30 17:35:43-05:00,Edwards Lifesciences Q4 2018 Earnings Preview,No summary available.,EW,en,Seeking Alpha
2019-01-25 01:36:52-05:00,Healthcare Winners And Losers If This Shutdown Is Prolonged,No summary available.,EW,en,Seeking Alpha
2019-01-22 09:17:07-05:00,Neovasc up 28% premarket on settlement of patent infringement action by Edwards,No summary available.,EW,en,Seeking Alpha
2019-01-22 09:17:07-05:00,Neovasc up 28% premarket on settlement of patent infringement action by Edwards,No summary available.,EW,en,Seeking Alpha
2019-01-15 09:51:10-05:00,Device makers in the green after BSX and EW settle patent fights,Boston Scientific and Edwards Lifesciences are leading device makers in early trade after agreeing to settle their patent disputes. Selected tickers: ([[GM,EW,en,Seeking Alpha
2019-01-15 09:51:10-05:00,Device makers in the green after BSX and EW settle patent fights,Boston Scientific and Edwards Lifesciences are leading device makers in early trade after agreeing to settle their patent disputes. Selected tickers: ([[GM,EW,en,Seeking Alpha
2019-01-15 09:45:56-05:00,Boston Sci and Edwards rally after resolution of patient disputes,Boston Scientific ([[BSX]] +3.4%) and Edwards Lifesciences ([[EW]] +6%) are both up in early trade after settling their global patent rows.,EW,en,Seeking Alpha
2019-01-15 09:45:56-05:00,Boston Sci and Edwards rally after resolution of patient disputes,Boston Scientific ([[BSX]] +3.4%) and Edwards Lifesciences ([[EW]] +6%) are both up in early trade after settling their global patent rows.,EW,en,Seeking Alpha
2019-01-15 07:14:36-05:00,Boston Scientific and Edwards Lifesciences settle global patent disputes,"Boston Scientific (BSX) and Edwards Lifesciences (EW) have settled all outstanding global patent disputes. All pending cases or appeals will be dismissed,",EW,en,Seeking Alpha
2019-01-15 07:14:36-05:00,Boston Scientific and Edwards Lifesciences settle global patent disputes,"Boston Scientific (BSX) and Edwards Lifesciences (EW) have settled all outstanding global patent disputes. All pending cases or appeals will be dismissed,",EW,en,Seeking Alpha
2019-01-09 13:30:47-05:00,Edwards Lifesciences (EW) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow,No summary available.,EW,en,Seeking Alpha
2019-01-09 13:30:47-05:00,Edwards Lifesciences (EW) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow,No summary available.,EW,en,Seeking Alpha
